top of page
Webmaster
Admin
More actions
Profile
Join date: Dec 22, 2019
Posts (3)
Mar 6, 2026 ∙ 3 min
China Introduces Pre-Communication Mechanism for Pharmacoeconomic Comparators
In February 2026, China’s National Healthcare Security Administration (NHSA) introduced the Measures for Pre-Communication on Reference Drugs (Interim) . While technical in nature, the policy represents an interesting initiative within China’s evolving pharmacoeconomic framework and may have practical implications for companies preparing for reimbursement discussions. At its core, the new mechanism allows pharmaceutical companies to communicate with the NHSA in advance to determine the...
7
0
Jan 25, 2026 ∙ 2 min
MAAB Group Announces Strategic Partnership to Commercialise Sancuso® in Greater China
[Auckland, New Zealand] — MAAB Group today announced the signing of a strategic licensing agreement to bring Sancuso® (granisetron transdermal system) across Greater China. Under the agreement, MAAB will assume exclusive manufacturing and commercialisation rights for Sancuso® in the region. The company plans to establish local production capacity in China to improve accessibility for patients and ensure a stable, cost-efficient supply chain. Sancuso ® Relaunch Marks First Step of...
62
0
2
Jul 2, 2024 ∙ 2 min
Streamline Your Medical Needs with MAAB Group's Reference Medicine Sourcing Service
In the ever-evolving world of healthcare, having reliable access to high-quality reference medicines is essential for research,...
26
0
1
bottom of page
